Intraoperative glycemic control using an artificial endocrine pancreas in a patient with a recurrent pleural solitary fibrous tumor producing insulin-like growth factor 2: a case report
Abstract Background Non-islet cell tumor producing insulin-like growth factor 2 involves hypoglycemia. During tumor resection, intense fluctuation of blood glucose level may occur. An artificial endocrine pancreas has been reported as beneficial for patients with insulinoma as it maintains stable gl...
Main Authors: | , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
SpringerOpen
2019-02-01
|
Series: | JA Clinical Reports |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s40981-019-0229-y |
id |
doaj-e1600c72aae24010871322148fd1c42a |
---|---|
record_format |
Article |
spelling |
doaj-e1600c72aae24010871322148fd1c42a2021-03-02T04:42:54ZengSpringerOpenJA Clinical Reports2363-90242019-02-01511410.1186/s40981-019-0229-yIntraoperative glycemic control using an artificial endocrine pancreas in a patient with a recurrent pleural solitary fibrous tumor producing insulin-like growth factor 2: a case reportKenzaburou Sugimoto0Rina Tokitou1Mamoru Kadosaki2Mamoru Takeuchi3Department of Anesthesiology and Critical Care Medicine, Jichi Medical UniversityDepartment of Anesthesiology and Critical Care Medicine, Jichi Medical UniversityDepartment of Anesthesiology and Critical Care Medicine, Jichi Medical UniversityDepartment of Anesthesiology and Critical Care Medicine, Jichi Medical UniversityAbstract Background Non-islet cell tumor producing insulin-like growth factor 2 involves hypoglycemia. During tumor resection, intense fluctuation of blood glucose level may occur. An artificial endocrine pancreas has been reported as beneficial for patients with insulinoma as it maintains stable glycemic levels, although scarcely described with insulin-like growth factor 2-releasing tumor. Case presentation An 84-year-old man had a recurrent left pleural solitary fibrous tumor releasing high molecular weight insulin-like growth factor 2 and experienced a frequent syncope accompanied by hypoglycemia. After anesthesia induction, an artificial endocrine pancreas, STG-55, was connected to the patient. Blood glucose level was stable at around 150 mg/dl during the resection surgery. The patient followed an uneventful course and was discharged without any complications. Conclusions An artificial endocrine pancreas may have the potential to stabilize the intraoperative blood glucose change in insulin-like growth factor 2-releasing tumor resection.http://link.springer.com/article/10.1186/s40981-019-0229-ySolitary fibrous tumorArtificial endocrine pancreasInsulin-like growth factor 2Non-islet cell tumor hypoglycemia |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Kenzaburou Sugimoto Rina Tokitou Mamoru Kadosaki Mamoru Takeuchi |
spellingShingle |
Kenzaburou Sugimoto Rina Tokitou Mamoru Kadosaki Mamoru Takeuchi Intraoperative glycemic control using an artificial endocrine pancreas in a patient with a recurrent pleural solitary fibrous tumor producing insulin-like growth factor 2: a case report JA Clinical Reports Solitary fibrous tumor Artificial endocrine pancreas Insulin-like growth factor 2 Non-islet cell tumor hypoglycemia |
author_facet |
Kenzaburou Sugimoto Rina Tokitou Mamoru Kadosaki Mamoru Takeuchi |
author_sort |
Kenzaburou Sugimoto |
title |
Intraoperative glycemic control using an artificial endocrine pancreas in a patient with a recurrent pleural solitary fibrous tumor producing insulin-like growth factor 2: a case report |
title_short |
Intraoperative glycemic control using an artificial endocrine pancreas in a patient with a recurrent pleural solitary fibrous tumor producing insulin-like growth factor 2: a case report |
title_full |
Intraoperative glycemic control using an artificial endocrine pancreas in a patient with a recurrent pleural solitary fibrous tumor producing insulin-like growth factor 2: a case report |
title_fullStr |
Intraoperative glycemic control using an artificial endocrine pancreas in a patient with a recurrent pleural solitary fibrous tumor producing insulin-like growth factor 2: a case report |
title_full_unstemmed |
Intraoperative glycemic control using an artificial endocrine pancreas in a patient with a recurrent pleural solitary fibrous tumor producing insulin-like growth factor 2: a case report |
title_sort |
intraoperative glycemic control using an artificial endocrine pancreas in a patient with a recurrent pleural solitary fibrous tumor producing insulin-like growth factor 2: a case report |
publisher |
SpringerOpen |
series |
JA Clinical Reports |
issn |
2363-9024 |
publishDate |
2019-02-01 |
description |
Abstract Background Non-islet cell tumor producing insulin-like growth factor 2 involves hypoglycemia. During tumor resection, intense fluctuation of blood glucose level may occur. An artificial endocrine pancreas has been reported as beneficial for patients with insulinoma as it maintains stable glycemic levels, although scarcely described with insulin-like growth factor 2-releasing tumor. Case presentation An 84-year-old man had a recurrent left pleural solitary fibrous tumor releasing high molecular weight insulin-like growth factor 2 and experienced a frequent syncope accompanied by hypoglycemia. After anesthesia induction, an artificial endocrine pancreas, STG-55, was connected to the patient. Blood glucose level was stable at around 150 mg/dl during the resection surgery. The patient followed an uneventful course and was discharged without any complications. Conclusions An artificial endocrine pancreas may have the potential to stabilize the intraoperative blood glucose change in insulin-like growth factor 2-releasing tumor resection. |
topic |
Solitary fibrous tumor Artificial endocrine pancreas Insulin-like growth factor 2 Non-islet cell tumor hypoglycemia |
url |
http://link.springer.com/article/10.1186/s40981-019-0229-y |
work_keys_str_mv |
AT kenzaburousugimoto intraoperativeglycemiccontrolusinganartificialendocrinepancreasinapatientwitharecurrentpleuralsolitaryfibroustumorproducinginsulinlikegrowthfactor2acasereport AT rinatokitou intraoperativeglycemiccontrolusinganartificialendocrinepancreasinapatientwitharecurrentpleuralsolitaryfibroustumorproducinginsulinlikegrowthfactor2acasereport AT mamorukadosaki intraoperativeglycemiccontrolusinganartificialendocrinepancreasinapatientwitharecurrentpleuralsolitaryfibroustumorproducinginsulinlikegrowthfactor2acasereport AT mamorutakeuchi intraoperativeglycemiccontrolusinganartificialendocrinepancreasinapatientwitharecurrentpleuralsolitaryfibroustumorproducinginsulinlikegrowthfactor2acasereport |
_version_ |
1724242974276059136 |